Physician

Jacquelyn Smith, M.D.

According to 2025 Medicare claims, Jacquelyn Smith, M.D. (NPI: 1154769131) practices internal medicine in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Jefferson, KY. This provider's primary affiliated billing organization is RHEUMATOLOGY ASSOCIATES, PLLC (NPI: 1396865580; TIN: 611183441) and primary practice location at 40218-2458.

Smith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 380 traditional Medicare patients, billed 92,032 HCPCS/CPT codes, and received $733,392 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 827 prescription claims across 204 beneficiaries totaling $245,942 in drug costs, led by Actemra Actpen (Tocilizumab). 2016 DME data shows 11 claims. Open Payments data shows 117 records totaling $4,330. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $28,252 and ending at $245,942. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	100	237	$13,887
2017	117	241	$14,591
2018	N/R	N/R	N/R
2019	154	15,698	$224,985
2020	475	119,299	$1,828,525
2021	532	113,837	$1,344,104
2022	474	100,925	$1,066,773
2023	495	137,604	$1,188,977
2024	380	92,032	$733,392

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	91	653	$28,252
2016	52	461	$16,490
2017	56	176	$29,100
2018	92	464	$261,373
2019	98	488	$438,394
2020	140	539	$85,397
2021	180	767	$255,605
2022	158	694	$220,108
2023	191	873	$261,075
2024	204	827	$245,942

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$1,616
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	74	104	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	194	275	$84
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	51	147	$50
76881	Complete ultrasound scan of joint	50	100	$38
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	157	199	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Actemra Actpen	Tocilizumab	11	308	$37,697
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	238	12,689	$6,079
Leflunomide	Leflunomide	42	2,460	$2,866
Methotrexate	Methotrexate Sodium	119	7,189	$2,677
Celecoxib	Celecoxib	24	1,198	$1,330

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	117	$4,330	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jacquelyn Smith, M.D.?

Tedicare shows public-source Medicare data for Jacquelyn Smith, M.D. (NPI 1154769131), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jacquelyn Smith, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jacquelyn Smith, M.D.?

Jacquelyn Smith, M.D. is linked to RHEUMATOLOGY ASSOCIATES, PLLC (billing NPI 1396865580) in the available physician profile data.

Does Jacquelyn Smith, M.D. have Open Payments data?

Jacquelyn Smith, M.D. has 117 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.